<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2B0F97E4-31D8-4D0A-9F3D-BCBF30B574C5"><gtr:id>2B0F97E4-31D8-4D0A-9F3D-BCBF30B574C5</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Wakelam</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FB%2F0000H213"><gtr:id>2B64DAEF-5044-420C-A6D4-A2A0B073DE8B</gtr:id><gtr:title>Programme in Lipidomic Oncology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/B/0000H213</gtr:grantReference><gtr:abstractText>The control of cell function by changes in gene expression is ultimately reflected in metabolic changes. Lipids are both important metabolites and key regulators in cells. It is now clear that an individual cell can contain thousands of distinct lipid species and that the pattern of these changes in disease. In this project we aim to determine changes that are associated with the progression of cancer and thus identify disease-associated changes which may point to novel sites for therapeutic intervention.</gtr:abstractText><gtr:fund><gtr:end>2009-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-06-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>163723</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This work together with others worldwide contributed to establishing lipidomics as a key methodology in the study of cell function in health and disease. This was through the development of mass spectrometry methodologies and through key nomenclature developments.</gtr:description><gtr:exploitationPathways>This has provided methods of use to other labs.</gtr:exploitationPathways><gtr:id>34585AF9-0427-4DDC-BB26-EF9E724BEE85</gtr:id><gtr:outcomeId>56d963708b0956.05165594</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>84BFB520-9DB3-467E-A0A9-3643CF4573CD</gtr:id><gtr:title>Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis.</gtr:title><gtr:parentPublicationTitle>Journal of cellular biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc713c10b28c875531e6946a6b87080c"><gtr:id>bc713c10b28c875531e6946a6b87080c</gtr:id><gtr:otherNames>Kilbey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0730-2312</gtr:issn><gtr:outcomeId>5a840bc1ebde07.74938344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56FBAF31-99EB-41EE-9DE5-9CCED20132EE</gtr:id><gtr:title>Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f74e18abfb905c3f3ec881f9b1087dc"><gtr:id>3f74e18abfb905c3f3ec881f9b1087dc</gtr:id><gtr:otherNames>Muinonen-Martin AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>56af82de8e6a74.01672081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F20357-59BF-4059-A571-AE40F2E57A57</gtr:id><gtr:title>Runx regulation of sphingolipid metabolism and survival signaling.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc713c10b28c875531e6946a6b87080c"><gtr:id>bc713c10b28c875531e6946a6b87080c</gtr:id><gtr:otherNames>Kilbey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>pm_5435b135b1369a66e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE47B27D-722F-4682-9036-30CAD3BB9EF0</gtr:id><gtr:title>Methods for analyzing phosphoinositides using mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b68d7053e20ab89ce875aeec9d21c3"><gtr:id>f9b68d7053e20ab89ce875aeec9d21c3</gtr:id><gtr:otherNames>Wakelam MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56bc9bbe451c63.57117356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7797BD75-4937-4C78-8E91-12C85AF4CD1E</gtr:id><gtr:title>Lipid systems and techniques. Introduction.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca07f9f94db2662bc0ea8295530c0bdf"><gtr:id>ca07f9f94db2662bc0ea8295530c0bdf</gtr:id><gtr:otherNames>Michael Wakelam (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>1064-3745</gtr:isbn><gtr:outcomeId>m_8091752105139917e6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DD13905-AA23-40F3-9617-546AB28A7D45</gtr:id><gtr:title>Fast targeted multidimensional NMR metabolomics of colorectal cancer.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in chemistry : MRC</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87592b4c08689b5b81e2104a23f486d4"><gtr:id>87592b4c08689b5b81e2104a23f486d4</gtr:id><gtr:otherNames>Ludwig C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0749-1581</gtr:issn><gtr:outcomeId>pm_5435b135b135ded76</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FA25BB4-A1F6-4CA2-984C-A49DFB58DEB3</gtr:id><gtr:title>Update of the LIPID MAPS comprehensive classification system for lipids.</gtr:title><gtr:parentPublicationTitle>Journal of lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28bb8e0b50536d05ab70f15ed25ffc93"><gtr:id>28bb8e0b50536d05ab70f15ed25ffc93</gtr:id><gtr:otherNames>Fahy E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2275</gtr:issn><gtr:outcomeId>pm_5435b135b1376aa19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92C223D4-01B5-4F3B-A000-E68BE0DAF9AA</gtr:id><gtr:title>Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edc5f7c0e58dfe61e7f81d9f8d2b7544"><gtr:id>edc5f7c0e58dfe61e7f81d9f8d2b7544</gtr:id><gtr:otherNames>Clark J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>56bc9c842be4c4.67476356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2B6763D-8E6A-405D-A63A-4750788CB318</gtr:id><gtr:title>Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120893d6db842ae2fac96265727b0fb4"><gtr:id>120893d6db842ae2fac96265727b0fb4</gtr:id><gtr:otherNames>Huang-Doran I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>5a9fb83d27c570.73214690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1452B56B-DFCF-4290-9611-A6A2D531C1AF</gtr:id><gtr:title>SnapShot: Lipid kinase and phosphatase reaction pathways.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/121c965a262c02ad2d9a6b3f0242bd09"><gtr:id>121c965a262c02ad2d9a6b3f0242bd09</gtr:id><gtr:otherNames>Rudge SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>54511c1aed0044.35018596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>275DDFDD-D0F9-4A09-A34F-50A1936AC4AC</gtr:id><gtr:title>The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.</gtr:title><gtr:parentPublicationTitle>Molecular carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/012898a7c14605d6a0c62c3803d6c2c7"><gtr:id>012898a7c14605d6a0c62c3803d6c2c7</gtr:id><gtr:otherNames>Read ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0899-1987</gtr:issn><gtr:outcomeId>56af82de60c8f6.89886165</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/B/0000H213</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>